Table 1.
Apoptosis
| Cell signaling agent | Organ or action | Reference |
| (1) MAP kinases | Human breast cancer cell MCF-11 | 47 |
| (2) Fas redistribution in the rafts | Colon cancer cells | 48 |
| (3) Ceramide | Breast cancer cells | 49 |
| (4) STAT3 and nuclear factor-κB-regulation | Human multiple myceloma cells | 50 |
| (5) Protein kinases and p38 kinase | Antitumor activity | 51 |
| (6) Src and Stat3 | Breast cancer | 52 |
| (7) TRAIL-induced | Mitochondria | 53 |
| (8) Phosphorylated Akt and Caspace-9 | MCF7 human breast cancer cells | 54 |
| (9) Cdc42 activation of ASK1/JNK | Human leukemia cancer cells | 55 |
| (10) Phosphatidylinositol 3′-kinase Akt | Human prostate cancer cells | 56 |
| (11) WAF-1/p21-mediated G1 phase | Human epidermoid Carcinoma A431 cells | 57 |
| (12) AMPK | Colon cancer cells | 58 |
| (13) JNK and c-JUN/AP-1 | Prevented HNE-induced JNK | 59 |
| (14) c-Myc | Downregulation in human medulloblastoma | 60 |
| (15) ERK | Initiates p53 dependent apoptosis via αVβ3 | 61 |
| (16) Caspase-3 | Human breast cancer cell | 62 |
| (17) CD95 | Human tumor cells | 63 |
| (18) TNBS | Inhibiting Notch pathway | 64 |
| (19) p53 and P13K/Akt | Human T-cell acute lymphoblastic leukemia MOLT-4 cells | 65 |